Earth Science Tech, Inc. Stock Other OTC
Equities
ETST
US2703111037
Pharmaceuticals
Financials (USD)
Sales 2022 | 14.12K | Sales 2023 | 48.54K | Capitalization | 9.24M |
---|---|---|---|---|---|
Net income 2022 | 3M | Net income 2023 | - | EV / Sales 2022 | 103 x |
Net Debt 2022 | 656K | Net Debt 2023 | 1.06M | EV / Sales 2023 | 212 x |
P/E ratio 2022 |
0.25
x | P/E ratio 2023 |
-13.8
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 39.91% |
Managers | Title | Age | Since |
---|---|---|---|
Giorgio Saumat
CEO | Chief Executive Officer | 44 | 22-09-30 |
Mario Tabraue
COO | Chief Operating Officer | 45 | 21-10-31 |
Sergio Castillo
SAM | Sales & Marketing | 40 | 17-01-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mario Tabraue
COO | Chief Operating Officer | 45 | 21-10-31 |
Giorgio Saumat
CEO | Chief Executive Officer | 44 | 22-09-30 |
Yovan Sanchez
BRD | Director/Board Member | 43 | Nov. 06 |
1st Jan change | Capi. | |
---|---|---|
+25.61% | 660B | |
+25.87% | 562B | |
-5.24% | 358B | |
+16.49% | 322B | |
+8.28% | 297B | |
+7.09% | 219B | |
-9.12% | 196B | |
+5.01% | 199B | |
-8.75% | 149B |